Jean-francois Bonfanti
Val-de-la-haye, 27106, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Discovery of JNJ-1802, a First-in-Class Pan-Serotype Dengue Virus NS4B Inhibitor.
Journal: Journal of medicinal chemistry
Published: March 14, 2024
Discovery of Acyl-Indole Derivatives as Pan-Serotype Dengue Virus NS4B Inhibitors.
Journal: Journal of medicinal chemistry
Published: June 30, 2023
Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B/NS3 and blocks replication organelle formation.
Journal: Nature communications
Published: June 26, 2023
From Oxetane to Thietane: Extending the Antiviral Spectrum of 2'-Spirocyclic Uridines by Substituting Oxygen with Sulfur.
Journal: ACS medicinal chemistry letters
Published: August 10, 2022
Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates.
Journal: Nature
Published: June 29, 2022
Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction.
Journal: Nature
Published: October 21, 2021
A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction.
Journal: Nature
Published: June 30, 2020
Toward the Synthesis of Fluorinated Analogues of HCV NS3/4A Serine Protease Inhibitors Using Methyl α-Amino-β-fluoro-β-vinylcyclopropanecarboxylate as Key Intermediate.
Journal: Organic letters
Published: June 09, 2015
Development of a high-throughput antiviral assay for screening inhibitors of chikungunya virus and generation of drug-resistant mutations in cultured cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 04, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026